Kenzo Muramoto

1.8k total citations
19 papers, 720 citations indexed

About

Kenzo Muramoto is a scholar working on Immunology, Oncology and Rheumatology. According to data from OpenAlex, Kenzo Muramoto has authored 19 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Oncology and 5 papers in Rheumatology. Recurrent topics in Kenzo Muramoto's work include Sleep and related disorders (3 papers), Circadian rhythm and melatonin (3 papers) and Chemokine receptors and signaling (3 papers). Kenzo Muramoto is often cited by papers focused on Sleep and related disorders (3 papers), Circadian rhythm and melatonin (3 papers) and Chemokine receptors and signaling (3 papers). Kenzo Muramoto collaborates with scholars based in Japan, United States and Germany. Kenzo Muramoto's co-authors include Toshio Imai, Miyuki Nishimura, Nobuyuki Miyasaka, Toshihiro Nanki, Yoshikazu Kuboi, Tetsu Kawano, Toshinori Nakayama, Tetsuo Kubota, Yasuyo Urasaki and Shigeru Kakuta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Annals of the New York Academy of Sciences.

In The Last Decade

Kenzo Muramoto

19 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenzo Muramoto Japan 11 387 210 108 86 79 19 720
Paola Portararo Italy 15 357 0.9× 243 1.2× 366 3.4× 77 0.9× 45 0.6× 23 947
Paul Smith United States 11 253 0.7× 164 0.8× 127 1.2× 36 0.4× 89 1.1× 26 694
Katja Hardt Germany 13 358 0.9× 95 0.5× 188 1.7× 45 0.5× 91 1.2× 18 623
Undine Proschmann Germany 14 257 0.7× 138 0.7× 211 2.0× 40 0.5× 79 1.0× 29 778
Xiaohan Hu China 14 153 0.4× 161 0.8× 227 2.1× 48 0.6× 57 0.7× 37 567
Alain H. Rook United States 7 274 0.7× 103 0.5× 69 0.6× 118 1.4× 36 0.5× 7 636
Duncan M. Morgan United States 11 374 1.0× 248 1.2× 324 3.0× 79 0.9× 45 0.6× 18 890
Laura Mercurio Italy 13 309 0.8× 109 0.5× 180 1.7× 36 0.4× 59 0.7× 22 561
Maria A. Beamer United States 8 280 0.7× 133 0.6× 128 1.2× 60 0.7× 92 1.2× 9 601
Bárbara Alonso Spain 14 262 0.7× 93 0.4× 109 1.0× 46 0.5× 45 0.6× 22 527

Countries citing papers authored by Kenzo Muramoto

Since Specialization
Citations

This map shows the geographic impact of Kenzo Muramoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenzo Muramoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenzo Muramoto more than expected).

Fields of papers citing papers by Kenzo Muramoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenzo Muramoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenzo Muramoto. The network helps show where Kenzo Muramoto may publish in the future.

Co-authorship network of co-authors of Kenzo Muramoto

This figure shows the co-authorship network connecting the top 25 collaborators of Kenzo Muramoto. A scholar is included among the top collaborators of Kenzo Muramoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenzo Muramoto. Kenzo Muramoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Inoue, Yuichi, Naoki Kubota, Michinori Koebis, et al.. (2022). Comparison of the treatment effectiveness between lemborexant and zolpidem tartrate extended-release for insomnia disorder subtypes defined based on polysomnographic findings. Journal of Clinical Sleep Medicine. 19(3). 519–528. 10 indexed citations
2.
3.
Takahashi, Masato, Kenichi Inoue, Hirofumi Mukai, et al.. (2021). Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in Japan. Breast Cancer. 28(4). 945–955. 10 indexed citations
4.
Kishi, Taro, Michinori Koebis, Kenzo Muramoto, et al.. (2021). Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review. Neuropsychopharmacology Reports. 41(4). 450–458. 21 indexed citations
5.
Nishikawa, Ryo, et al.. (2021). Safety of Gliadel Implant for Malignant Glioma: Report of Postmarketing Surveillance in Japan. Neurologia medico-chirurgica. 61(9). 536–548. 12 indexed citations
6.
Koyama, Noriyuki, et al.. (2021). Preclinical and clinical efficacy of orexin receptor antagonist Lemborexant (Dayvigo<sup>®</sup>) on insomnia patients. Folia Pharmacologica Japonica. 156(2). 114–119. 1 indexed citations
7.
8.
Makino, Takamitsu, Hironobu Ihn, Motoo Nakagawa, et al.. (2020). Effect of adalimumab on axial manifestations in Japanese patients with psoriatic arthritis: a 24 week prospective, observational study. Lara D. Veeken. 60(8). 3669–3678. 2 indexed citations
9.
10.
Kuboi, Yoshikazu, Miyuki Nishimura, Wataru Ikeda, et al.. (2019). Blockade of the fractalkine–CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytes. International Immunology. 31(5). 287–302. 20 indexed citations
11.
Chino, Takenao, Noritaka Oyama, Minoru Hasegawa, et al.. (2016). Anti-CX3CL1 monoclonal antibody: A promising therapy for systemic sclerosis. Journal of Dermatological Science. 84(1). e111–e112. 1 indexed citations
12.
Hayashizaki, Koji, Motoko Y. Kimura, Koji Tokoyoda, et al.. (2016). Myosin light chains 9 and 12 are functional ligands for CD69 that regulate airway inflammation. Science Immunology. 1(3). eaaf9154–eaaf9154. 54 indexed citations
13.
Tanaka, Kéiichi, Masaaki Mikami, Yoko Inoue, et al.. (2014). The combined effects of iguratimod with anti-TNF^|^alpha; antibody on experimental arthritis models in mice. Inflammation and Regeneration. 34(3). 157–164. 1 indexed citations
14.
Kaneko, Kayoko, Yoshishige Miyabe, Shin Fukuda, et al.. (2011). Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis. Arthritis Research & Therapy. 13(5). R158–R158. 93 indexed citations
15.
Nishimura, Miyuki, Yoshikazu Kuboi, Kenzo Muramoto, Tetsu Kawano, & Toshio Imai. (2009). Chemokines as Novel Therapeutic Targets for Inflammatory Bowel Disease. Annals of the New York Academy of Sciences. 1173(1). 350–356. 89 indexed citations
16.
Kawahara, Tetsuya, K. Okano, Hiromitsu Yokohama, et al.. (2004). Piperidine Carboxylic Acid Derivatives of 10H-Pyrazino[2,3-b][1,4]benzothiazine as Orally-Active Adhesion Molecule Inhibitors. Chemical and Pharmaceutical Bulletin. 52(6). 675–687. 9 indexed citations
17.
Nanki, Toshihiro, Yasuyo Urasaki, Toshio Imai, et al.. (2004). Inhibition of Fractalkine Ameliorates Murine Collagen-Induced Arthritis. The Journal of Immunology. 173(11). 7010–7016. 119 indexed citations
18.
Kawahara, Tetsuya, K. Okano, Hiromitsu Yokohama, et al.. (2002). Inhibitors of Adhesion Molecules Expression; The Synthesis and Pharmacological Properties of 10H-Pyrazino[2,3-b][1,4]benzothiazine Derivatives.. Chemical and Pharmaceutical Bulletin. 50(7). 922–929. 20 indexed citations
19.
Seino, Ken‐ichiro, Katashi Fukao, Kenzo Muramoto, et al.. (2001). Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proceedings of the National Academy of Sciences. 98(5). 2577–2581. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Portararo Breakdown of academic impact, for papers by Paul Smith Breakdown of academic impact, for papers by Katja Hardt Breakdown of academic impact, for papers by Undine Proschmann Breakdown of academic impact, for papers by Xiaohan Hu Breakdown of academic impact, for papers by Alain H. Rook Breakdown of academic impact, for papers by Duncan M. Morgan Breakdown of academic impact, for papers by Laura Mercurio Breakdown of academic impact, for papers by Maria A. Beamer Breakdown of academic impact, for papers by Bárbara Alonso
Rankless by CCL
2026